Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Globalisation

Globalisation

When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.

Drug ingredients were key to Ireland's manufacturing growth in 2013 says CSO

21-Jul-2014 - Basic pharmaceuticals including APIs became even more important revenue generators for Ireland in 2013 according to new data released by the Central Statistics Office (CSO).

FDA proposed rule could delay import of excipients, PhRMA says

15-Jul-2014 - Although industry group PhRMA has called for the full implementation of a proposed rule that would allow the US FDA to destroy detained drugs deemed to be counterfeit or unapproved,...

Actavis cuts down Forest as $26bn acquisition closes

10-Jul-2014 - Actavis says it is closing facilities in St. Louis, Missouri affecting 190 jobs a week after completing the $28bn (€21bn) acquisition of Forest Laboratories.

China demands ‘famous brand’ suppliers and added value, says Romaco

30-Jun-2014 - Chinese pharma is looking for added value and “famous brands” from its processing providers, the tableting and packaging supplier Romaco has said. 

Teva's 70+ manufacturing sites could be halved in efficiency drive

12-Jun-2014 - Teva could halve its manufacturing network as part of its $2bn-a-year efficiency programme says CFO Eyal Desheh, with most cuts hitting its core generics business.

Foreign execs flocking to Asia to meet growth demands, says recruiter

12-Jun-2014 - Local talent is not satisfying the “tremendous” demand for top-level pharma employees in Asia and recruiters are searching internationally for candidates, a pharmaceutical head-hunter has said.

Actavis' $48m investment reassuring for Puerto Rico, says PRIDCO

05-Jun-2014 - The Puerto Rico Industrial Development Company (PRIDCO) says Actavis’ investment at two facilities is evidence of continued pharma growth, despite a number of recent closures on the island.

EU austerity hurting generics firms and may cost jobs says industry group

03-Jun-2014 - European pharmaceutical manufacturing jobs are at risk according to a group representing generic firms which says price caps in EU member states are hurting drugmakers.

Pfizer JV indicative of burgeoning UAE drug sector says DuBiotech

03-Jun-2014 - Tax breaks and the promise of preferential treament for locally made drugs were key to attracting Pfizer to the UAE says DuBiotech.

Boehringer Ingelheim eyes growing Saudi market with local collaborations

06-May-2014 - Boehringer Ingelheim says the Saudi Arabian market is a huge drive for big pharma as it teams with local firms to manufacture secondary packaging for 26 products.

Bayer buys Merck & Co.'s OTC business for $14.2bn

06-May-2014 - Bayer says it will become the OTC leader in North America having acquired Merck & Co.’s consumer health business for $14.2bn (€10.2bn), in the latest shift in Big Pharma assets....

Hospira: New Vizag plant online this year despite US FDA 483

05-May-2014 - Hospira says approval for its new manufacturing facility in India is still on track despite receiving a Form 483 form the US FDA with ten observations.

Emerging excipient markets to outpace Western markets, report says

30-Apr-2014 - Experts have predicted emerging Indian and Chinese markets will outpace Western markets as the $2.3bn oral solid dosage form (OSDF) excipients global market grows at a sustainable rate.

Industry seeks to expand investments in manufacturing, report finds

28-Apr-2014 - As pharma manufacturers look to cut costs and increase quality, over 70% of industry executives interviewed for a recent CPhI report say they are actively investing in manufacturing techniques and...

Indian state regulator suspends manufacture of drug at Wockhardt plant

24-Apr-2014 - Indian authorities have suspended the manufacture of a Wockhardt fixed dose combination drug, the company has announced in a filing.

INFOGRAPHIC

AZ for $100bn? Pfizer could buy Azerbaijan and keep the change

22-Apr-2014 - With Pfizer rumoured to be on the brink of a mega-merger with AstraZeneca, in-Pharmatechnologist.com brings you an interactive view of what £60bn ($101bn) could get.

US to lose 140,000 jobs if status quo is maintained, PhRMA reports

18-Apr-2014 - Biopharma executives believe there will be strong growth in domestic R&D activities and biopharma manufacturing, but fewer workers will be needed as efficiencies in productivity are achieved across the industry,...

Novartis eyes Asian market with $160m Singapore ophthalmic plant

15-Apr-2014 - Novartis subsidiary Alcon has opened the doors to its new $160m facility in Singapore for the manufacture of ophthalmic drugs.

Governments urged to rethink stockpiling after Tamiflu and Relenza reviewed

10-Apr-2014 - Tamiflu shortens the duration of influenza symptoms by only half a day, does not stop person-to-person spread and increases the risk of nausea say the authors of a new review...

Lupin: Mexican buy a bridgehead to generics and API growth

01-Apr-2014 - Lupin has bought Mexican eye drugmaker Grin in a deal that gives it a “bridgehead” to grow its API and generics business in the region.

GSK to invest $166m in manufacturing in Sub-Saharan Africa

31-Mar-2014 - GSK says it intends to build five new drug manufacturing as part of a £130m ($215m) investment in sub-Saharan Africa.

Hospira edges closer to completion of Orchid API deal in India

18-Mar-2014 - The Board of Directors at Indian firm Orchid has approved the sale of its API business to Hospira, bringing the acquisition a step closer to completion.

Opportunities outweigh risks in China, says Eli Lilly

17-Mar-2014 - Eli Lilly says the opportunities in China outweigh any perceived challenges as it begins a $70m expansion of its manufacturing joint venture.

Pfizer invests in Indonesian solid dose facility

11-Mar-2014 - Pfizer’s $3.5m expansion of an Indonesian solid oral dose plant will increase capacity by 76%, the company says.

‘New’ Ranbaxy generic Lipitor recall took place in January

10-Mar-2014 - Publication of a US FDA enforcement report detailing a recall by Ranbaxy in January saw the beleaguered Indian drugmakers’ share price fall 3% last week.

Key Industry Events

 

Access all events listing

Our events, Events from partners...